Pharmaceuticals in South Korea
Published: November 2012 · Publisher: MarketLine
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016).
- Description
- Table of Contents
- Ask a Question
Introduction
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Korea pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
*The South Korean pharmaceuticals market had total revenues of $14 billion in 2011, representing a compound annual growth rate (CAGR) of 5.2% between 2007 and 2011.
*0
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.6% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $17.5 billion by the end of 2016.
Features
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts
Macroeconomic indicators provide insight into general trends within the South Korea economy
Key Questions Answered
What was the size of the South Korea pharmaceuticals market by value in 2011?
What will be the size of the South Korea pharmaceuticals market in 2016?
What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
How has the market performed over the last five years?
Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Korea pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
*The South Korean pharmaceuticals market had total revenues of $14 billion in 2011, representing a compound annual growth rate (CAGR) of 5.2% between 2007 and 2011.
*0
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.6% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $17.5 billion by the end of 2016.
Features
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts
Macroeconomic indicators provide insight into general trends within the South Korea economy
Key Questions Answered
What was the size of the South Korea pharmaceuticals market by value in 2011?
What will be the size of the South Korea pharmaceuticals market in 2016?
What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
How has the market performed over the last five years?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Daewoong Pharmaceutical Co., Ltd. 20
Hanmi Holdings Co., Ltd. 23
Dong-A Pharmaceutical Co., Ltd. 26
Macroeconomic Indicators 29
Country Data 29
Appendix 31
Methodology 31
Industry associations 32
Related research 32
LIST OF TABLES
Table 1: South Korea pharmaceuticals market value: $ billion, 2007–11 8
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2011 9
Table 3: South Korea pharmaceuticals market share: % share, by value, 2011 10
Table 4: South Korea pharmaceuticals market value forecast: $ billion, 2011–16 11
Table 5: Daewoong Pharmaceutical Co., Ltd.: key facts 20
Table 6: Daewoong Pharmaceutical Co., Ltd.: key financials ($) 21
Table 7: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW) 21
Table 8: Daewoong Pharmaceutical Co., Ltd.: key financial ratios 21
Table 9: Hanmi Holdings Co., Ltd.: key facts 23
Table 10: Hanmi Holdings Co., Ltd.: key financials ($) 24
Table 11: Hanmi Holdings Co., Ltd.: key financials (KRW) 24
Table 12: Hanmi Holdings Co., Ltd.: key financial ratios 24
Table 13: Dong-A Pharmaceutical Co., Ltd.: key facts 26
Table 14: Dong-A Pharmaceutical Co., Ltd.: key financials ($) 26
Table 15: Dong-A Pharmaceutical Co., Ltd.: key financials (KRW) 27
Table 16: Dong-A Pharmaceutical Co., Ltd.: key financial ratios 27
Table 17: South Korea size of population (million), 2007–11 29
Table 18: South Korea gdp (constant 2000 prices, $ billion), 2007–11 29
Table 19: South Korea gdp (current prices, $ billion), 2007–11 29
Table 20: South Korea inflation, 2007–11 30
Table 21: South Korea consumer price index (absolute), 2007–11 30
Table 22: South Korea exchange rate, 2007–11 30
LIST OF FIGURES
Figure 1: South Korea pharmaceuticals market value: $ billion, 2007–11 8
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2011 9
Figure 3: South Korea pharmaceuticals market share: % share, by value, 2011 10
Figure 4: South Korea pharmaceuticals market value forecast: $ billion, 2011–16 11
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2011 12
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2011 13
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2011 15
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2011 16
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2011 18
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2011 19
Figure 11: Daewoong Pharmaceutical Co., Ltd.: revenues & profitability 22
Figure 12: Daewoong Pharmaceutical Co., Ltd.: assets & liabilities 22
Figure 13: Hanmi Holdings Co., Ltd.: revenues & profitability 25
Figure 14: Hanmi Holdings Co., Ltd.: assets & liabilities 25
Figure 15: Dong-A Pharmaceutical Co., Ltd.: revenues & profitability 27
Figure 16: Dong-A Pharmaceutical Co., Ltd.: assets & liabilities 28
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Daewoong Pharmaceutical Co., Ltd. 20
Hanmi Holdings Co., Ltd. 23
Dong-A Pharmaceutical Co., Ltd. 26
Macroeconomic Indicators 29
Country Data 29
Appendix 31
Methodology 31
Industry associations 32
Related research 32
LIST OF TABLES
Table 1: South Korea pharmaceuticals market value: $ billion, 2007–11 8
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2011 9
Table 3: South Korea pharmaceuticals market share: % share, by value, 2011 10
Table 4: South Korea pharmaceuticals market value forecast: $ billion, 2011–16 11
Table 5: Daewoong Pharmaceutical Co., Ltd.: key facts 20
Table 6: Daewoong Pharmaceutical Co., Ltd.: key financials ($) 21
Table 7: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW) 21
Table 8: Daewoong Pharmaceutical Co., Ltd.: key financial ratios 21
Table 9: Hanmi Holdings Co., Ltd.: key facts 23
Table 10: Hanmi Holdings Co., Ltd.: key financials ($) 24
Table 11: Hanmi Holdings Co., Ltd.: key financials (KRW) 24
Table 12: Hanmi Holdings Co., Ltd.: key financial ratios 24
Table 13: Dong-A Pharmaceutical Co., Ltd.: key facts 26
Table 14: Dong-A Pharmaceutical Co., Ltd.: key financials ($) 26
Table 15: Dong-A Pharmaceutical Co., Ltd.: key financials (KRW) 27
Table 16: Dong-A Pharmaceutical Co., Ltd.: key financial ratios 27
Table 17: South Korea size of population (million), 2007–11 29
Table 18: South Korea gdp (constant 2000 prices, $ billion), 2007–11 29
Table 19: South Korea gdp (current prices, $ billion), 2007–11 29
Table 20: South Korea inflation, 2007–11 30
Table 21: South Korea consumer price index (absolute), 2007–11 30
Table 22: South Korea exchange rate, 2007–11 30
LIST OF FIGURES
Figure 1: South Korea pharmaceuticals market value: $ billion, 2007–11 8
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2011 9
Figure 3: South Korea pharmaceuticals market share: % share, by value, 2011 10
Figure 4: South Korea pharmaceuticals market value forecast: $ billion, 2011–16 11
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2011 12
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2011 13
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2011 15
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2011 16
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2011 18
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2011 19
Figure 11: Daewoong Pharmaceutical Co., Ltd.: revenues & profitability 22
Figure 12: Daewoong Pharmaceutical Co., Ltd.: assets & liabilities 22
Figure 13: Hanmi Holdings Co., Ltd.: revenues & profitability 25
Figure 14: Hanmi Holdings Co., Ltd.: assets & liabilities 25
Figure 15: Dong-A Pharmaceutical Co., Ltd.: revenues & profitability 27
Figure 16: Dong-A Pharmaceutical Co., Ltd.: assets & liabilities 28
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.